ArticleTransplantation proceedings2025
Two Cases of Post-Kidney Transplantation Thrombotic Microangiopathy From a Single Donor With Candidemia.
Article in Transplantation proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Thrombotic microangiopathy (TMA) secondary to donor-derived infections remains a rare, yet serious source of graft loss and increased patient morbidity and mortality. Among TMA etiologies, donor-derived fungal infections remain particularly challenging to test for pre-operatively and treat post-operatively. We describe 2 cases of post-kidney transplant TMA from a single donor with suspected candidemia. Despite prophylactic treatment for Candida with fluconazole and eculizumab for TMA, 1 of the 2 patients unfortunately succumbed to TMA-related complications. The other patient, who also received fluconazole and eculizumab, had persistent hemolysis and ultimately required a transplant nephrectomy. Following nephrectomy, the patient's symptoms and laboratory values improved and the patient was able to be discharged to inpatient rehab before returning home. Despite appropriate treatment for Candida and TMA, patient outcomes were unfavorable. These 2 cases underscore the difficulties in treating TMA in the setting of organ transplantation and candidemia, pointing to the necessity for more research into improved treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.